http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201492271-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-52
filingDate 2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201492271-A1
titleOfInvention CHROMAN CONNECTIONS
abstract The invention relates to a compound that is useful as an active ingredient in a pharmaceutical composition, in particular a pharmaceutical composition for the prevention or treatment of conditions associated with and / or mediated by β-secretase activity, hydrolysis of the β-secretase cleavage site of the amyloid precursor protein and / or protein accumulation β-amyloid, including pharmaceutical compositions for prophylaxis or treatment, including without limitation glaucoma, MCI (mild cognitive impairment) or Alzheimer's disease, mainly Alzheimer's disease.
priorityDate 2012-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08592
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39244
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95241
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11820
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28280
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO73683
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP53601
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86810
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID31002
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374198
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403407
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28053
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39399
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58083
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP79307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136319
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0A3Z4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425701257
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47566
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5IS80
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05067
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0A3Z3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID828049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0A3Z2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12023
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397663
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0A3Z1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO93279
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP75313
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29216
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID351
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ60495
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28757
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395564
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86906
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28748
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280722
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID473931
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID54226

Total number of triples: 56.